There are distinct challenges in the development of biosimilars and biologics. You may find yourself seeking guidance at every step — all the way from R&D to sales and marketing. Chiltern’s Collaborative Approach and experienced teams can help you determine the best development approach, manage your risks and optimize the return on your investment throughout your entire program’s process.
Chiltern offers a full range of services and solutions to provide you with the expertise, technology and data you need all the way from patient recruitment through regulatory submission:
Biosimilars & Biologics Services
- Clinical Development
- Medical & Scientific Affairs
- Data & Analysis
- Strategic Regulatory